English
This article is from Journal of Pharmacology & Pharmacotherapeutics , volume 5 . Abstract The risk for angioedema has been suggested lower with angiotensin receptor blockers (ARBs) than with angiotensin-converting enzyme inhibitors (ACEIs) or aliskiren. Many isolated reports do exist, reporting angioedema with ARBs such as olmesartan, valsartan, losartan and telmisartan. To the best of our knowledge this is the first case report of telmisartan plus ramipril fixed dose combination leading to angioedema from India questioning the rationality of ARBs plus ACEIs combination in the treatment of hypertension.
Sign in with your free account to read, download EPUBs or listen.
Ebook · Angioedema due to fixed dose combination of telmisartan plus ramipril. · Tandon, Vishal R., Mahajan, Annil, Khajuria, Vijay, Gillani, Zahid H. · Internet Archive